NO304409B1 - Synergetiske antimalariasammensetninger inneholdende benflumetol - Google Patents

Synergetiske antimalariasammensetninger inneholdende benflumetol

Info

Publication number
NO304409B1
NO304409B1 NO933271A NO933271A NO304409B1 NO 304409 B1 NO304409 B1 NO 304409B1 NO 933271 A NO933271 A NO 933271A NO 933271 A NO933271 A NO 933271A NO 304409 B1 NO304409 B1 NO 304409B1
Authority
NO
Norway
Prior art keywords
flumetol
synergetic
compositions containing
antimalarial
containing bone
Prior art date
Application number
NO933271A
Other languages
English (en)
Norwegian (no)
Other versions
NO933271L (no
NO933271D0 (no
Inventor
Anton Alexander Poltera
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1993/000163 external-priority patent/WO1993015727A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO933271L publication Critical patent/NO933271L/no
Publication of NO933271D0 publication Critical patent/NO933271D0/no
Publication of NO304409B1 publication Critical patent/NO304409B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO933271A 1992-02-07 1993-09-14 Synergetiske antimalariasammensetninger inneholdende benflumetol NO304409B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92810089 1992-02-07
EP92810130 1992-02-21
PCT/EP1993/000163 WO1993015727A1 (en) 1992-02-07 1993-01-25 Antimalarial synergistic compositions containing benflumetol

Publications (3)

Publication Number Publication Date
NO933271L NO933271L (no) 1993-09-14
NO933271D0 NO933271D0 (no) 1993-09-14
NO304409B1 true NO304409B1 (no) 1998-12-14

Family

ID=26132495

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933271A NO304409B1 (no) 1992-02-07 1993-09-14 Synergetiske antimalariasammensetninger inneholdende benflumetol

Country Status (6)

Country Link
AT (1) ATE177631T1 (de)
DE (1) DE69323941T2 (de)
ES (1) ES2130250T3 (de)
NO (1) NO304409B1 (de)
OA (1) OA10057A (de)
RU (1) RU2118158C1 (de)

Also Published As

Publication number Publication date
NO933271L (no) 1993-09-14
ATE177631T1 (de) 1999-04-15
RU2118158C1 (ru) 1998-08-27
NO933271D0 (no) 1993-09-14
DE69323941T2 (de) 1999-08-26
ES2130250T3 (es) 1999-07-01
DE69323941D1 (de) 1999-04-22
OA10057A (fr) 1996-10-14

Similar Documents

Publication Publication Date Title
EA199700277A1 (ru) Соединения, ингибирующие фарнезил-протеинтрансферазу, и фармацевтическая композиция на их основе
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
MX9202181A (es) Compuestos arilicos y heteroarilicos bis mono y biciclicos que inhiben la tirosina quinasa de receptor de egf y/o pdgf.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9814327A (pt) Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose
PT661992E (pt) Formulacoes farmaceuticas de inibidores de interleucina-1
DE69837324D1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
DE69432984D1 (de) Therapeutische substituierte guanidine
LU90366I2 (fr) Nasonex
BE902897A (fr) Derives 3-aminopropoxyaryliques, leur preparation leur application comme medicaments et compositions pharmaceutiques les contenant
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
PT964687E (pt) Composicoes farmaceuticas com actividade antimicrobiana
KR960006915A (ko) 췌장염의 치료 조성물
EA200100956A1 (ru) Фармацевтические композиции на основе тизоксанида и нитазоксанида
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
NO304409B1 (no) Synergetiske antimalariasammensetninger inneholdende benflumetol
FR2381034A1 (fr) Compositions pharmaceutiques analgesiques et anti-inflammatoires a base de 1,3,5-triazine
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
AR019817A1 (es) Compuestos multiadherentes, uso de dichos compuestos para preparar un medicamento util para tratar mamiferos que tienen una enfermedad que es aliviadamediante tratamiento con un agente antibacteriano, procedimiento para la preparacion de dichos compuestos y composicion farmaceutica que los contiene
ES2164911T3 (es) Composicion farmaceutica que contiene inhibidores de interferon gamma.
BR9909971A (pt) Uso de um composto, processo para tratamento ou prevenção da sìndrome de intestinos irritáveis, e, composição farmacêutica para o tratamento da sìndrome dos intestinos irritáveis
ATE100713T1 (de) L-alpha-glycerophosphoryl-d-myoinositol zur behandlung peripherer neuropathien und cerebropathien.
SE8403659D0 (sv) Synergistic pharmaceutical composition
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
FI914410A0 (fi) Kalciumupptagande inhibitorer.

Legal Events

Date Code Title Description
MK1K Patent expired